0.7569USD-4.19%Mkt Cap: 29.99M USDP/E: —Last update: 2026-05-26
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure …
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap29.99M USD
Enterprise Value—
Revenue (TTM)67.68M USD
Gross Profit11.70M USD
Net Income (TTM)-5.31M USD
Revenue/Share1.814 USD
Last Price0.7569 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees157
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS7743743004
Valuation
P/E (Trailing)—
P/E (Forward)11.57
PEG4.43
EV/EBITDA—
EV/Revenue—
P/S0.47
P/B0.86
EPS (TTM)-0.15
EPS (Forward)0.07
52W Range
0.74001% of range2.100
52W High2.100 USD
52W Low0.7400 USD
Profitability
Gross Margin16.89%
Oper. Margin-8.54%
EBITDA Margin-3.86%
Profit Margin-7.67%
ROE-14.37%
ROA-9.30%
Growth
Revenue Growth-8.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-659.00K USD
CapEx (TTM)542.00K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.24
Current Ratio—
Quick Ratio—
Book Value/Sh0.9380 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:11
Split DateMay 13, 2022
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)3.000 USD
Target Range2.000 USD – 4.000 USD
# Analysts2
Ownership
Shares Out.39.47M
Float35.20M
Insiders12.25%
Institutions10.13%
Short Interest
Short Ratio2.0d
Short % Float1.01%
Short % Out.0.98%
Shares Short387.45K
Short (prev mo.)743.23K
Technical
SMA 500.9006 (-16.0%)
SMA 2001.047 (-27.7%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)265.79K
Avg Vol (10d)230.59K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—